- Home
- AU vs PODD Comparison
AU vs PODD Comparison
Compare AU & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- PODD
- Stock Information
- Founded
- AU 1944
- PODD 2000
- Country
- AU United States
- PODD United States
- Employees
- AU N/A
- PODD N/A
- Industry
- AU Precious Metals
- PODD Medical/Dental Instruments
- Sector
- AU Basic Materials
- PODD Health Care
- Exchange
- AU Nasdaq
- PODD Nasdaq
- Market Cap
- AU 18.3B
- PODD 18.2B
- IPO Year
- AU 1972
- PODD 2007
- Fundamental
- Price
- AU $43.48
- PODD $325.03
- Analyst Decision
- AU Hold
- PODD Buy
- Analyst Count
- AU 5
- PODD 18
- Target Price
- AU $41.30
- PODD $317.61
- AVG Volume (30 Days)
- AU 3.1M
- PODD 986.1K
- Earning Date
- AU 05-09-2025
- PODD 05-08-2025
- Dividend Yield
- AU 2.08%
- PODD N/A
- EPS Growth
- AU N/A
- PODD 67.46
- EPS
- AU 3.06
- PODD 5.55
- Revenue
- AU $6,585,000,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- AU $48.30
- PODD $23.72
- Revenue Next Year
- AU $2.56
- PODD $17.56
- P/E Ratio
- AU $14.29
- PODD $58.58
- Revenue Growth
- AU 39.37
- PODD 23.48
- 52 Week Low
- AU $22.13
- PODD $172.07
- 52 Week High
- AU $46.90
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- AU 57.62
- PODD 70.12
- Support Level
- AU $42.74
- PODD $315.91
- Resistance Level
- AU $44.52
- PODD $329.10
- Average True Range (ATR)
- AU 1.14
- PODD 6.82
- MACD
- AU 0.06
- PODD -0.15
- Stochastic Oscillator
- AU 81.46
- PODD 81.61
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.